nodes	percent_of_prediction	percent_of_DWPC	metapath
Etodolac—Abnormal faeces—Octreotide—thymus cancer	0.0569	0.0569	CcSEcCtD
Etodolac—Hepatitis cholestatic—Octreotide—thymus cancer	0.0403	0.0403	CcSEcCtD
Etodolac—Stomach ache—Octreotide—thymus cancer	0.0382	0.0382	CcSEcCtD
Etodolac—Ulcerative stomatitis—Octreotide—thymus cancer	0.0352	0.0352	CcSEcCtD
Etodolac—Epigastric pain—Octreotide—thymus cancer	0.0336	0.0336	CcSEcCtD
Etodolac—Peptic ulcer—Octreotide—thymus cancer	0.0243	0.0243	CcSEcCtD
Etodolac—Burning sensation—Octreotide—thymus cancer	0.0234	0.0234	CcSEcCtD
Etodolac—Nephrolithiasis—Octreotide—thymus cancer	0.0202	0.0202	CcSEcCtD
Etodolac—Jaundice cholestatic—Octreotide—thymus cancer	0.0185	0.0185	CcSEcCtD
Etodolac—Rectal haemorrhage—Octreotide—thymus cancer	0.018	0.018	CcSEcCtD
Etodolac—Hearing impaired—Octreotide—thymus cancer	0.0171	0.0171	CcSEcCtD
Etodolac—Eructation—Octreotide—thymus cancer	0.016	0.016	CcSEcCtD
Etodolac—Cystitis noninfective—Octreotide—thymus cancer	0.0159	0.0159	CcSEcCtD
Etodolac—Cystitis—Octreotide—thymus cancer	0.0157	0.0157	CcSEcCtD
Etodolac—Urine output increased—Octreotide—thymus cancer	0.0147	0.0147	CcSEcCtD
Etodolac—Bladder pain—Octreotide—thymus cancer	0.0147	0.0147	CcSEcCtD
Etodolac—Mouth ulceration—Octreotide—thymus cancer	0.0147	0.0147	CcSEcCtD
Etodolac—Polyuria—Octreotide—thymus cancer	0.0134	0.0134	CcSEcCtD
Etodolac—Deafness—Octreotide—thymus cancer	0.0132	0.0132	CcSEcCtD
Etodolac—Cardiac failure congestive—Octreotide—thymus cancer	0.013	0.013	CcSEcCtD
Etodolac—Visual disturbance—Octreotide—thymus cancer	0.0124	0.0124	CcSEcCtD
Etodolac—Anaphylactoid reaction—Octreotide—thymus cancer	0.0122	0.0122	CcSEcCtD
Etodolac—Gastrointestinal haemorrhage—Octreotide—thymus cancer	0.0118	0.0118	CcSEcCtD
Etodolac—Irritability—Octreotide—thymus cancer	0.0113	0.0113	CcSEcCtD
Etodolac—Abdominal pain upper—Octreotide—thymus cancer	0.0108	0.0108	CcSEcCtD
Etodolac—Gastritis—Octreotide—thymus cancer	0.0104	0.0104	CcSEcCtD
Etodolac—Abdominal distension—Octreotide—thymus cancer	0.0103	0.0103	CcSEcCtD
Etodolac—Asthma—Octreotide—thymus cancer	0.0102	0.0102	CcSEcCtD
Etodolac—Bronchospasm—Octreotide—thymus cancer	0.01	0.01	CcSEcCtD
Etodolac—Pancreatitis—Octreotide—thymus cancer	0.01	0.01	CcSEcCtD
Etodolac—Bronchitis—Octreotide—thymus cancer	0.0098	0.0098	CcSEcCtD
Etodolac—Abdominal discomfort—Octreotide—thymus cancer	0.00977	0.00977	CcSEcCtD
Etodolac—Dysuria—Octreotide—thymus cancer	0.00953	0.00953	CcSEcCtD
Etodolac—Pollakiuria—Octreotide—thymus cancer	0.00942	0.00942	CcSEcCtD
Etodolac—Hyperglycaemia—Octreotide—thymus cancer	0.0092	0.0092	CcSEcCtD
Etodolac—Pneumonia—Octreotide—thymus cancer	0.00914	0.00914	CcSEcCtD
Etodolac—Jaundice—Octreotide—thymus cancer	0.00886	0.00886	CcSEcCtD
Etodolac—Conjunctivitis—Octreotide—thymus cancer	0.00884	0.00884	CcSEcCtD
Etodolac—Haematuria—Octreotide—thymus cancer	0.00867	0.00867	CcSEcCtD
Etodolac—Sinusitis—Octreotide—thymus cancer	0.00853	0.00853	CcSEcCtD
Etodolac—Rhinitis—Octreotide—thymus cancer	0.00818	0.00818	CcSEcCtD
Etodolac—Hepatitis—Octreotide—thymus cancer	0.00816	0.00816	CcSEcCtD
Etodolac—Pharyngitis—Octreotide—thymus cancer	0.0081	0.0081	CcSEcCtD
Etodolac—Visual impairment—Octreotide—thymus cancer	0.00786	0.00786	CcSEcCtD
Etodolac—Tinnitus—Octreotide—thymus cancer	0.00761	0.00761	CcSEcCtD
Etodolac—Flushing—Octreotide—thymus cancer	0.00757	0.00757	CcSEcCtD
Etodolac—Arrhythmia—Octreotide—thymus cancer	0.00729	0.00729	CcSEcCtD
Etodolac—Alopecia—Octreotide—thymus cancer	0.00721	0.00721	CcSEcCtD
Etodolac—Flatulence—Octreotide—thymus cancer	0.007	0.007	CcSEcCtD
Etodolac—Tension—Octreotide—thymus cancer	0.00697	0.00697	CcSEcCtD
Etodolac—Nervousness—Octreotide—thymus cancer	0.0069	0.0069	CcSEcCtD
Etodolac—Vision blurred—Octreotide—thymus cancer	0.00669	0.00669	CcSEcCtD
Etodolac—Tremor—Octreotide—thymus cancer	0.00666	0.00666	CcSEcCtD
Etodolac—Ill-defined disorder—Octreotide—thymus cancer	0.00659	0.00659	CcSEcCtD
Etodolac—Anaemia—Octreotide—thymus cancer	0.00657	0.00657	CcSEcCtD
Etodolac—Malaise—Octreotide—thymus cancer	0.00641	0.00641	CcSEcCtD
Etodolac—Vertigo—Octreotide—thymus cancer	0.00638	0.00638	CcSEcCtD
Etodolac—Syncope—Octreotide—thymus cancer	0.00637	0.00637	CcSEcCtD
Etodolac—Palpitations—Octreotide—thymus cancer	0.00628	0.00628	CcSEcCtD
Etodolac—Loss of consciousness—Octreotide—thymus cancer	0.00624	0.00624	CcSEcCtD
Etodolac—Convulsion—Octreotide—thymus cancer	0.00615	0.00615	CcSEcCtD
Etodolac—Hypertension—Octreotide—thymus cancer	0.00613	0.00613	CcSEcCtD
Etodolac—Arthralgia—Octreotide—thymus cancer	0.00605	0.00605	CcSEcCtD
Etodolac—Myalgia—Octreotide—thymus cancer	0.00605	0.00605	CcSEcCtD
Etodolac—Anxiety—Octreotide—thymus cancer	0.00603	0.00603	CcSEcCtD
Etodolac—Discomfort—Octreotide—thymus cancer	0.00598	0.00598	CcSEcCtD
Etodolac—Dry mouth—Octreotide—thymus cancer	0.00591	0.00591	CcSEcCtD
Etodolac—Anaphylactic shock—Octreotide—thymus cancer	0.0058	0.0058	CcSEcCtD
Etodolac—Oedema—Octreotide—thymus cancer	0.0058	0.0058	CcSEcCtD
Etodolac—Infection—Octreotide—thymus cancer	0.00576	0.00576	CcSEcCtD
Etodolac—Shock—Octreotide—thymus cancer	0.0057	0.0057	CcSEcCtD
Etodolac—Thrombocytopenia—Octreotide—thymus cancer	0.00568	0.00568	CcSEcCtD
Etodolac—Tachycardia—Octreotide—thymus cancer	0.00566	0.00566	CcSEcCtD
Etodolac—Hyperhidrosis—Octreotide—thymus cancer	0.0056	0.0056	CcSEcCtD
Etodolac—Anorexia—Octreotide—thymus cancer	0.00553	0.00553	CcSEcCtD
Etodolac—Musculoskeletal discomfort—Octreotide—thymus cancer	0.00528	0.00528	CcSEcCtD
Etodolac—Insomnia—Octreotide—thymus cancer	0.00524	0.00524	CcSEcCtD
Etodolac—Paraesthesia—Octreotide—thymus cancer	0.00521	0.00521	CcSEcCtD
Etodolac—Dyspnoea—Octreotide—thymus cancer	0.00517	0.00517	CcSEcCtD
Etodolac—Somnolence—Octreotide—thymus cancer	0.00515	0.00515	CcSEcCtD
Etodolac—Dyspepsia—Octreotide—thymus cancer	0.0051	0.0051	CcSEcCtD
Etodolac—Decreased appetite—Octreotide—thymus cancer	0.00504	0.00504	CcSEcCtD
Etodolac—Fatigue—Octreotide—thymus cancer	0.005	0.005	CcSEcCtD
Etodolac—Constipation—Octreotide—thymus cancer	0.00496	0.00496	CcSEcCtD
Etodolac—Pain—Octreotide—thymus cancer	0.00496	0.00496	CcSEcCtD
Etodolac—Feeling abnormal—Octreotide—thymus cancer	0.00478	0.00478	CcSEcCtD
Etodolac—Gastrointestinal pain—Octreotide—thymus cancer	0.00474	0.00474	CcSEcCtD
Etodolac—Urticaria—Octreotide—thymus cancer	0.00461	0.00461	CcSEcCtD
Etodolac—Abdominal pain—Octreotide—thymus cancer	0.00458	0.00458	CcSEcCtD
Etodolac—Body temperature increased—Octreotide—thymus cancer	0.00458	0.00458	CcSEcCtD
Etodolac—Hypersensitivity—Octreotide—thymus cancer	0.00427	0.00427	CcSEcCtD
Etodolac—Asthenia—Octreotide—thymus cancer	0.00416	0.00416	CcSEcCtD
Etodolac—Pruritus—Octreotide—thymus cancer	0.0041	0.0041	CcSEcCtD
Etodolac—Diarrhoea—Octreotide—thymus cancer	0.00397	0.00397	CcSEcCtD
Etodolac—Dizziness—Octreotide—thymus cancer	0.00383	0.00383	CcSEcCtD
Etodolac—Vomiting—Octreotide—thymus cancer	0.00369	0.00369	CcSEcCtD
Etodolac—Rash—Octreotide—thymus cancer	0.00366	0.00366	CcSEcCtD
Etodolac—Dermatitis—Octreotide—thymus cancer	0.00365	0.00365	CcSEcCtD
Etodolac—Headache—Octreotide—thymus cancer	0.00363	0.00363	CcSEcCtD
Etodolac—Nausea—Octreotide—thymus cancer	0.00344	0.00344	CcSEcCtD
